Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Reproductive Health Program in Patients With Cancer | Standard practice related to reproductive heath, Training modules, algorithm, referral development | NCT01806129 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... | Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT02568566 | National Cancer Institute (NCI) | Active, not recruiting |
| Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention | NCT05008848 | Alliance for Clinical Trials in Oncology | Recruiting |
| Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who... | Laboratory Biomarker Analysis, Trastuzumab, Whole Breast Irradiation | NCT00769379 | National Cancer Institute (NCI) | Active, not recruiting |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection... | Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate | NCT03887702 | Southwest Oncology Group | Active, not recruiting |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT03036930 | National Cancer Institute (NCI) | Active, not recruiting |
| Prevention of Oral DNA Damage by Black Raspberries | BRB Lozenges | NCT04372914 | Milton S. Hershey Medical Center | Recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... | Endocrine therapy interruption | NCT02308085 | ETOP IBCSG Partners Foundation | Active, not recruiting |
| Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... | Denosumab, Salpingo-Oophorectomy | NCT03382574 | National Cancer Institute (NCI) | Recruiting |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration | NCT03317405 | National Cancer Institute (NCI) | Active, not recruiting |
Why I Joined a Clinical Trial
There are many ways we can create a legacy for our family. There are even fewer opportunities to create a legacy for humanity. Participating in clinical trials gives us a chance to do both.